Navigation Links
MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
Date:9/18/2007

NEW JERSEY, Sept. 18 /PRNewswire-FirstCall/ - MaxLife Fund Corp. (OTC: MXFD), is pleased to announce that they have appointed Daniel E. Kahan to its' Advisory Board.

Mr. Kahan has an extensive international actuarial background in the life insurance industry. He has hands-on experience and knowledge of the life settlements market in North America. After earning a B.Sc. (Honors) in Mathematics from University College, London, England, he qualified as an Associate of the Institute of Actuaries in 1984. He worked for 3 years in South Africa for Metropolitan Life, before moving to North America. In Toronto, Ontario, Canada he worked for Sun Life and Zurich Life. He also worked for Blue Cross in Chicago, Illinois, U.S.A.

In 1994 he founded Canadian Life Line in Nova Scotia, to provide insurance secured loans, with the approval of the Nova Scotia Superintendent of Loans & Insurance. In July 2001 he was a panel member at the Society of Actuaries Product Development Meeting session in Toronto on Life Settlements.

"Life Settlements is one of the fastest growing sectors and I am looking forward to assist MaxLife Fund Corp. to become one of the leading companies in this industry," stated Mr. Kahan.

Bennett Kurtz, Chairman and CEO, "As we are in the process of building a strong team to lead MaxLife Fund Corp., we welcome Mr. Kahan, and value his experience and expertise in the Life Settlement industry."

MaxLife Fund Corp. is a fund designated to excel in the Life Settlement sector and to partner with revenue generating businesses that are profitable, in the health sector. MaxLife is committed to create value for its shareholders by becoming one of the leading funds in the life and health sector.

Cautionary Statement Pursuant to Safe Harbor Provisions of the Private

Securities Litigation Reform Act of 1995:

This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Expressions of future goals and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties. The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. The Company undertakes no obligations to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this news release.


'/>"/>
SOURCE MaxLife Fund Corp.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Oracle Corp. to help build worlds first "Digital Hospital"
2. WHO lifts HongKong advisory
3. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
4. Doctors Said – ‘Stop Pressurising NHS Advisory Bod’
5. Mercks Pain Reliever Arcoxia Rejected by US Federal Advisory Panel
6. FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too
7. FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too
8. LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation
9. Study casts doubt on keyboard ills
10. Who Board To Discuss Asian Tsunami Related Health Issues
11. Abdominal Crunches Not The Best Option For Wash Board Abs.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... , ... February 09, 2016 , ... ... helping businesses recover after a disaster, announced today the acquisition of Hawaii DKI. ... Hawaii. , “Investing in like-minded companies who excel at service and ...
(Date:2/9/2016)... Cambridge, MA (PRWEB) , ... February 09, 2016 ... ... Institute (WCRI) compares the workers’ compensation fee schedule rates and Medicare rates for ... medical services covered in the report, Evaluation of the 2015 Fee Schedule ...
(Date:2/9/2016)... Springs, FL (PRWEB) , ... February 09, 2016 ... ... leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ ... for each prescription referral received at our specialty pharmacy. , “Since our ...
(Date:2/9/2016)... ... 10, 2016 , ... The Journal of Pain Research has published ... .” , As corresponding author Dr John F. Peppin says “Terminology matters, yet little ... chronic pain patients. ‘Chronic cancer pain’ and ‘chronic non-cancer pain’ are replete in ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... service to expand access to affordable hearing aids , increase industry transparency, ... individuals in the United States. , “For the average consumer, the hearing aid ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb.8, 2016 Aesthetic Devices - Medical ... Devices sector report, "Aesthetic Devices - Medical Devices Pipeline ... in pipeline stage. This report is ... primary research by GlobalData,s team of industry experts. ... or altered based on the availability and relevance of ...
(Date:2/8/2016)... N.J. , Feb. 8, 2016  Otsuka Pharmaceutical ... announced that they have entered into a licensing agreement ... in the U.S. and Puerto Rico ... a topical, non-steroidal phosphodiesterase IV (PDE-4) inhibitor, a new ... --> In a Phase II clinical ...
(Date:2/8/2016)... 2016  Echo Therapeutics, Inc. (Nasdaq: ... on non-invasive continuous glucose monitoring (CGM) and ... it will host a webcast and conference ... 9:00 a.m. Eastern Time to provide a ... advancements in its CGM system, and its ...
Breaking Medicine Technology: